Share Price and Basic Stock Data
Last Updated: February 25, 2025, 10:33 am
PEG Ratio | 0.45 |
---|
Competitors of Zen Technologies Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
MTAR Technologies Ltd | 4,287 Cr. | 1,394 | 2,200/1,207 | 95.8 | 228 | 0.00 % | 11.4 % | 8.37 % | 10.0 |
DCX Systems Ltd | 2,919 Cr. | 262 | 452/235 | 55.8 | 102 | 0.00 % | 9.27 % | 8.08 % | 2.00 |
Data Patterns (India) Ltd | 9,127 Cr. | 1,630 | 3,655/1,405 | 51.0 | 241 | 0.40 % | 19.7 % | 14.3 % | 2.00 |
Paras Defence and Space Technologies Ltd | 3,614 Cr. | 897 | 1,593/609 | 61.9 | 119 | 0.00 % | 11.4 % | 7.96 % | 10.0 |
Zen Technologies Ltd | 9,922 Cr. | 1,099 | 2,628/809 | 47.3 | 173 | 0.09 % | 47.2 % | 33.0 % | 1.00 |
Industry Average | 42,331.00 Cr | 1,021.08 | 53.01 | 150.75 | 0.38% | 22.03% | 16.34% | 4.92 |
Quarterly Result
Metric | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 16 | 12 | 16 | 33 | 21 | 33 | 74 | 132 | 64 | 98 | 136 | 254 | 242 |
Expenses | 15 | 11 | 16 | 22 | 16 | 25 | 48 | 66 | 42 | 54 | 91 | 151 | 162 |
Operating Profit | 1 | 1 | -0 | 11 | 5 | 8 | 26 | 66 | 22 | 44 | 45 | 103 | 79 |
OPM % | 7% | 8% | -1% | 34% | 26% | 25% | 35% | 50% | 34% | 45% | 33% | 41% | 33% |
Other Income | 1 | 1 | 2 | 2 | 3 | 4 | 0 | 3 | 5 | 4 | 5 | 3 | 8 |
Interest | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 |
Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
Profit before tax | 1 | 1 | 1 | 12 | 7 | 11 | 25 | 67 | 24 | 46 | 47 | 103 | 83 |
Tax % | 11% | 80% | -97% | 31% | 30% | 29% | 30% | 30% | 29% | 31% | 30% | 28% | 22% |
Net Profit | 1 | 0 | 1 | 8 | 5 | 8 | 17 | 47 | 17 | 32 | 33 | 74 | 65 |
EPS in Rs | 0.11 | 0.02 | 0.18 | 1.03 | 0.58 | 0.95 | 2.17 | 5.61 | 2.06 | 3.77 | 3.93 | 8.83 | 7.23 |
Last Updated: November 6, 2024, 7:30 pm
Profit & Loss - Annual Report
Last Updated: Unknown
Metric | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 37 | 46 | 79 | 53 | 62 | 39 | 92 | 147 | 50 | 54 | 161 | 430 | 552 |
Expenses | 33 | 46 | 58 | 48 | 50 | 41 | 70 | 83 | 42 | 52 | 110 | 253 | 338 |
Operating Profit | 5 | 1 | 21 | 4 | 12 | -2 | 23 | 64 | 8 | 2 | 51 | 177 | 214 |
OPM % | 12% | 1% | 27% | 8% | 19% | -5% | 24% | 43% | 16% | 4% | 32% | 41% | 39% |
Other Income | 5 | 4 | 3 | 5 | 4 | 4 | 3 | 2 | 3 | 5 | 9 | 16 | 17 |
Interest | 2 | 2 | 2 | 2 | 3 | 2 | 5 | 3 | 1 | 1 | 2 | 2 | 3 |
Depreciation | 2 | 2 | 2 | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 7 | 8 |
Profit before tax | 6 | 0 | 20 | 3 | 9 | -3 | 17 | 59 | 6 | 2 | 54 | 184 | 220 |
Tax % | 15% | 18% | 21% | 21% | 20% | -86% | -13% | -3% | 28% | -9% | 30% | 30% | |
Net Profit | 5 | 0 | 16 | 2 | 7 | -0 | 19 | 61 | 4 | 2 | 38 | 129 | 156 |
EPS in Rs | 0.53 | 0.01 | 2.04 | 0.30 | 0.96 | -0.05 | 2.49 | 7.84 | 0.52 | 0.25 | 4.73 | 15.38 | 18.59 |
Dividend Payout % | 19% | 858% | 2% | 33% | 16% | -198% | 12% | 5% | 19% | 39% | 4% | 0% |
YoY Net Profit Growth
Year | 2013-2014 | 2015-2016 | 2016-2017 | 2017-2018 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | -100.00% | -87.50% | 250.00% | -100.00% | 221.05% | -93.44% | -50.00% | 1800.00% | 239.47% |
Change in YoY Net Profit Growth (%) | 0.00% | 12.50% | 337.50% | -350.00% | 321.05% | -314.50% | 43.44% | 1850.00% | -1560.53% |
Zen Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 25% |
5 Years: | 36% |
3 Years: | 106% |
TTM: | 110% |
Compounded Profit Growth | |
---|---|
10 Years: | 107% |
5 Years: | 46% |
3 Years: | 215% |
TTM: | 85% |
Stock Price CAGR | |
---|---|
10 Years: | 34% |
5 Years: | 80% |
3 Years: | 77% |
1 Year: | 35% |
Return on Equity | |
---|---|
10 Years: | 14% |
5 Years: | 17% |
3 Years: | 18% |
Last Year: | 33% |
Last Updated: Unknown
Balance Sheet
Last Updated: December 14, 2024, 2:26 pm
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 9 |
Reserves | 98 | 91 | 103 | 105 | 112 | 111 | 133 | 191 | 205 | 284 | 311 | 445 | 1,556 |
Borrowings | 13 | 18 | 40 | 41 | 9 | 10 | 42 | 1 | 1 | 12 | 6 | 1 | 61 |
Other Liabilities | 5 | 12 | 27 | 14 | 16 | 36 | 41 | 14 | 10 | 54 | 121 | 264 | 207 |
Total Liabilities | 126 | 128 | 178 | 167 | 144 | 165 | 224 | 213 | 224 | 358 | 446 | 718 | 1,832 |
Fixed Assets | 29 | 49 | 47 | 44 | 45 | 65 | 63 | 64 | 62 | 59 | 67 | 79 | 88 |
CWIP | 3 | 1 | 0 | 15 | 17 | 0 | 0 | 0 | 0 | 3 | 2 | 10 | 14 |
Investments | 0 | 0 | 0 | 0 | 0 | 2 | 13 | 16 | 24 | 24 | 24 | 26 | 26 |
Other Assets | 94 | 78 | 130 | 108 | 82 | 98 | 147 | 133 | 137 | 272 | 353 | 603 | 1,703 |
Total Assets | 126 | 128 | 178 | 167 | 144 | 165 | 224 | 213 | 224 | 358 | 446 | 718 | 1,832 |
Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -8.00 | -17.00 | -19.00 | -37.00 | 3.00 | -12.00 | -19.00 | 63.00 | 7.00 | -10.00 | 45.00 | 176.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 127 | 90 | 276 | 56 | 120 | 212 | 290 | 110 | 128 | 133 | 150 | 143 |
Inventory Days | 212 | 295 | 225 | 242 | 237 | 1,181 | 496 | 97 | 396 | 625 | 368 | 355 |
Days Payable | 53 | 63 | 47 | 52 | 89 | 355 | 106 | 48 | 114 | 147 | 33 | 70 |
Cash Conversion Cycle | 286 | 322 | 455 | 246 | 267 | 1,038 | 681 | 159 | 410 | 612 | 484 | 429 |
Working Capital Days | 236 | 143 | 281 | 138 | 150 | 80 | 295 | 180 | 548 | 830 | 56 | 152 |
ROCE % | 6% | 2% | 16% | 3% | 9% | -0% | 14% | 32% | 3% | 1% | 17% | 47% |
This stock is not held by any mutual fund
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Basic EPS (Rs.) | 15.45 | 5.39 | 0.25 | 0.39 | 7.62 |
Diluted EPS (Rs.) | 15.34 | 5.20 | 0.25 | 0.39 | 7.62 |
Cash EPS (Rs.) | 16.56 | 7.05 | 0.93 | 0.97 | 8.19 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 55.48 | 32.13 | 27.05 | 26.49 | 25.63 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 55.48 | 32.13 | 27.05 | 26.49 | 25.63 |
Revenue From Operations / Share (Rs.) | 52.34 | 27.52 | 8.77 | 6.87 | 19.35 |
PBDIT / Share (Rs.) | 23.29 | 10.04 | 1.25 | 1.31 | 8.38 |
PBIT / Share (Rs.) | 22.13 | 9.28 | 0.64 | 0.68 | 7.79 |
PBT / Share (Rs.) | 22.15 | 9.02 | 0.41 | 0.54 | 7.35 |
Net Profit / Share (Rs.) | 15.41 | 6.28 | 0.32 | 0.34 | 7.60 |
NP After MI And SOA / Share (Rs.) | 15.22 | 5.38 | 0.24 | 0.39 | 7.62 |
PBDIT Margin (%) | 44.49 | 36.49 | 14.26 | 19.04 | 43.30 |
PBIT Margin (%) | 42.29 | 33.72 | 7.33 | 9.97 | 40.24 |
PBT Margin (%) | 42.32 | 32.77 | 4.73 | 7.98 | 38.00 |
Net Profit Margin (%) | 29.44 | 22.83 | 3.74 | 5.07 | 39.28 |
NP After MI And SOA Margin (%) | 29.07 | 19.52 | 2.84 | 5.69 | 39.36 |
Return on Networth / Equity (%) | 28.50 | 17.70 | 0.95 | 1.52 | 30.74 |
Return on Capital Employeed (%) | 38.70 | 22.12 | 1.72 | 2.55 | 29.92 |
Return On Assets (%) | 17.03 | 9.02 | 0.53 | 1.39 | 27.45 |
Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.02 | 0.01 | 0.01 |
Total Debt / Equity (X) | 0.00 | 0.02 | 0.06 | 0.01 | 0.01 |
Asset Turnover Ratio (%) | 0.71 | 0.39 | 0.18 | 0.22 | 0.68 |
Current Ratio (X) | 2.29 | 2.69 | 3.84 | 13.35 | 8.76 |
Quick Ratio (X) | 1.66 | 2.34 | 3.49 | 11.84 | 7.71 |
Inventory Turnover Ratio (X) | 1.58 | 1.93 | 1.00 | 0.64 | 1.10 |
Dividend Payout Ratio (NP) (%) | 1.30 | 1.85 | 40.05 | 102.21 | 3.93 |
Dividend Payout Ratio (CP) (%) | 1.21 | 1.62 | 11.66 | 39.44 | 3.65 |
Earning Retention Ratio (%) | 98.70 | 98.15 | 59.95 | -2.21 | 96.07 |
Cash Earning Retention Ratio (%) | 98.79 | 98.38 | 88.34 | 60.56 | 96.35 |
Interest Coverage Ratio (X) | 85.79 | 19.59 | 6.50 | 9.53 | 19.30 |
Interest Coverage Ratio (Post Tax) (X) | 56.71 | 12.77 | 2.89 | 3.54 | 18.51 |
Enterprise Value (Cr.) | 7886.73 | 2457.39 | 1565.48 | 585.38 | 159.51 |
EV / Net Operating Revenue (X) | 17.93 | 11.23 | 22.44 | 10.71 | 1.07 |
EV / EBITDA (X) | 40.30 | 30.77 | 157.39 | 56.26 | 2.47 |
MarketCap / Net Operating Revenue (X) | 18.25 | 11.90 | 23.34 | 11.32 | 1.18 |
Retention Ratios (%) | 98.69 | 98.14 | 59.94 | -2.21 | 96.06 |
Price / BV (X) | 17.89 | 10.79 | 7.82 | 3.03 | 0.91 |
Price / Net Operating Revenue (X) | 18.25 | 11.90 | 23.34 | 11.32 | 1.18 |
EarningsYield | 0.01 | 0.01 | 0.00 | 0.01 | 0.33 |
After reviewing the key financial ratios for Zen Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 15.45. This value is within the healthy range. It has increased from 5.39 (Mar 23) to 15.45, marking an increase of 10.06.
- For Diluted EPS (Rs.), as of Mar 24, the value is 15.34. This value is within the healthy range. It has increased from 5.20 (Mar 23) to 15.34, marking an increase of 10.14.
- For Cash EPS (Rs.), as of Mar 24, the value is 16.56. This value is within the healthy range. It has increased from 7.05 (Mar 23) to 16.56, marking an increase of 9.51.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 55.48. It has increased from 32.13 (Mar 23) to 55.48, marking an increase of 23.35.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 55.48. It has increased from 32.13 (Mar 23) to 55.48, marking an increase of 23.35.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 52.34. It has increased from 27.52 (Mar 23) to 52.34, marking an increase of 24.82.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 23.29. This value is within the healthy range. It has increased from 10.04 (Mar 23) to 23.29, marking an increase of 13.25.
- For PBIT / Share (Rs.), as of Mar 24, the value is 22.13. This value is within the healthy range. It has increased from 9.28 (Mar 23) to 22.13, marking an increase of 12.85.
- For PBT / Share (Rs.), as of Mar 24, the value is 22.15. This value is within the healthy range. It has increased from 9.02 (Mar 23) to 22.15, marking an increase of 13.13.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 15.41. This value is within the healthy range. It has increased from 6.28 (Mar 23) to 15.41, marking an increase of 9.13.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 15.22. This value is within the healthy range. It has increased from 5.38 (Mar 23) to 15.22, marking an increase of 9.84.
- For PBDIT Margin (%), as of Mar 24, the value is 44.49. This value is within the healthy range. It has increased from 36.49 (Mar 23) to 44.49, marking an increase of 8.00.
- For PBIT Margin (%), as of Mar 24, the value is 42.29. This value exceeds the healthy maximum of 20. It has increased from 33.72 (Mar 23) to 42.29, marking an increase of 8.57.
- For PBT Margin (%), as of Mar 24, the value is 42.32. This value is within the healthy range. It has increased from 32.77 (Mar 23) to 42.32, marking an increase of 9.55.
- For Net Profit Margin (%), as of Mar 24, the value is 29.44. This value exceeds the healthy maximum of 10. It has increased from 22.83 (Mar 23) to 29.44, marking an increase of 6.61.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 29.07. This value exceeds the healthy maximum of 20. It has increased from 19.52 (Mar 23) to 29.07, marking an increase of 9.55.
- For Return on Networth / Equity (%), as of Mar 24, the value is 28.50. This value is within the healthy range. It has increased from 17.70 (Mar 23) to 28.50, marking an increase of 10.80.
- For Return on Capital Employeed (%), as of Mar 24, the value is 38.70. This value is within the healthy range. It has increased from 22.12 (Mar 23) to 38.70, marking an increase of 16.58.
- For Return On Assets (%), as of Mar 24, the value is 17.03. This value is within the healthy range. It has increased from 9.02 (Mar 23) to 17.03, marking an increase of 8.01.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 24, the value is 0.00. This value is within the healthy range. It has decreased from 0.02 (Mar 23) to 0.00, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 0.71. It has increased from 0.39 (Mar 23) to 0.71, marking an increase of 0.32.
- For Current Ratio (X), as of Mar 24, the value is 2.29. This value is within the healthy range. It has decreased from 2.69 (Mar 23) to 2.29, marking a decrease of 0.40.
- For Quick Ratio (X), as of Mar 24, the value is 1.66. This value is within the healthy range. It has decreased from 2.34 (Mar 23) to 1.66, marking a decrease of 0.68.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.58. This value is below the healthy minimum of 4. It has decreased from 1.93 (Mar 23) to 1.58, marking a decrease of 0.35.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 1.30. This value is below the healthy minimum of 20. It has decreased from 1.85 (Mar 23) to 1.30, marking a decrease of 0.55.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 1.21. This value is below the healthy minimum of 20. It has decreased from 1.62 (Mar 23) to 1.21, marking a decrease of 0.41.
- For Earning Retention Ratio (%), as of Mar 24, the value is 98.70. This value exceeds the healthy maximum of 70. It has increased from 98.15 (Mar 23) to 98.70, marking an increase of 0.55.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 98.79. This value exceeds the healthy maximum of 70. It has increased from 98.38 (Mar 23) to 98.79, marking an increase of 0.41.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 85.79. This value is within the healthy range. It has increased from 19.59 (Mar 23) to 85.79, marking an increase of 66.20.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 56.71. This value is within the healthy range. It has increased from 12.77 (Mar 23) to 56.71, marking an increase of 43.94.
- For Enterprise Value (Cr.), as of Mar 24, the value is 7,886.73. It has increased from 2,457.39 (Mar 23) to 7,886.73, marking an increase of 5,429.34.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 17.93. This value exceeds the healthy maximum of 3. It has increased from 11.23 (Mar 23) to 17.93, marking an increase of 6.70.
- For EV / EBITDA (X), as of Mar 24, the value is 40.30. This value exceeds the healthy maximum of 15. It has increased from 30.77 (Mar 23) to 40.30, marking an increase of 9.53.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 18.25. This value exceeds the healthy maximum of 3. It has increased from 11.90 (Mar 23) to 18.25, marking an increase of 6.35.
- For Retention Ratios (%), as of Mar 24, the value is 98.69. This value exceeds the healthy maximum of 70. It has increased from 98.14 (Mar 23) to 98.69, marking an increase of 0.55.
- For Price / BV (X), as of Mar 24, the value is 17.89. This value exceeds the healthy maximum of 3. It has increased from 10.79 (Mar 23) to 17.89, marking an increase of 7.10.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 18.25. This value exceeds the healthy maximum of 3. It has increased from 11.90 (Mar 23) to 18.25, marking an increase of 6.35.
- For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation. If you have any questions or need more detailed insights, please feel free to reach out.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Zen Technologies Ltd:
- Net Profit Margin: 29.44%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 38.7% (Industry Average ROCE: 22.03%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 28.5% (Industry Average ROE: 16.34%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 56.71
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.66
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 47.3 (Industry average Stock P/E: 53.01)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 29.44%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Aerospace & Defense | B-42, Industrial Estate, Sanathnagar, Hyderabad Telangana 500018 | info@zentechnologies.com http://www.zentechnologies.com |
Management | |
---|---|
Name | Position Held |
Mr. Ashok Atluri | Chairman & Managing Director |
Mr. Kishore Dutt Atluri | Joint Managing Director |
Mr. Ravi Kumar Midathala | Whole Time Director |
Ms. Shilpa Choudari | Whole Time Director |
Ms. Sirisha Chintapalli | Independent Director |
Mr. Sanjay Vijay Singh Jesrani | Independent Director |
Dr. Ravindra Kumar Tyagi | Independent Director |
Dr. Ajay Kumar Singh | Independent Director |
FAQ
What is the latest intrinsic value of Zen Technologies Ltd?
Let's break down Zen Technologies Ltd's intrinsic value simply:
We calculate intrinsic value using the PE Ratio Method - comparing the company's current price-to-earnings ratio with its historical average and industry peers. Think of it like checking if a stock is "on sale" compared to its typical pricing.
As of 25 February 2025:
- Calculated Fair Value: ₹2162.23
- Current Market Price: ₹1,099.00
- Variance: 96.75% higher
This suggests Zen Technologies Ltd is currently undervalued by 96.75%. For context:
- Market Cap: 9,922 Cr.
- 52-Week Range: 2,628/809
- Reserves (Sep 2024): ₹1,556 Cr
- Liabilities: 1,832 Cr
Remember: The PE method gives a snapshot based on earnings multiples. While useful for quick comparisons, investors should also consider growth prospects, industry trends, and economic conditions. This calculation assumes historical PE ratios remain relevant - always verify with current market dynamics.
What is the Market Cap of Zen Technologies Ltd?
The Market Cap of Zen Technologies Ltd is 9,922 Cr..
What is the current Stock Price of Zen Technologies Ltd as on 25 February 2025?
The current stock price of Zen Technologies Ltd as on 25 February 2025 is ₹1,099.
What is the High / Low of Zen Technologies Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Zen Technologies Ltd stocks is 2,628/809.
What is the Stock P/E of Zen Technologies Ltd?
The Stock P/E of Zen Technologies Ltd is 47.3.
What is the Book Value of Zen Technologies Ltd?
The Book Value of Zen Technologies Ltd is 173.
What is the Dividend Yield of Zen Technologies Ltd?
The Dividend Yield of Zen Technologies Ltd is 0.09 %.
What is the ROCE of Zen Technologies Ltd?
The ROCE of Zen Technologies Ltd is 47.2 %.
What is the ROE of Zen Technologies Ltd?
The ROE of Zen Technologies Ltd is 33.0 %.
What is the Face Value of Zen Technologies Ltd?
The Face Value of Zen Technologies Ltd is 1.00.